BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 18983294)

  • 1. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
    Reddy MT; Patel H; Ventura HO
    Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pulmonary arterial hypertension.
    Humbert M; Sitbon O; Simonneau G
    N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
    Matthes J; Mathen F; Herzig S; Wassermann K
    Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction.
    Theodoraki K; Tsiapras D; Tsourelis L; Zarkalis D; Sfirakis P; Kapetanakis E; Alivizatos P; Antoniou T
    Acta Anaesthesiol Scand; 2006 Nov; 50(10):1213-7. PubMed ID: 16978158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veno-venous extracorporeal membrane oxygenation bridging to pharmacotherapy in pulmonary arterial hypertensive crisis.
    Srivastava MC; Ramani GV; Garcia JP; Griffith BP; Uber PA; Park MH
    J Heart Lung Transplant; 2010 Jul; 29(7):811-3. PubMed ID: 20417127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction.
    Wang A; Bashore TM
    Eur Heart J; 1997 Sep; 18(9):1364-5. PubMed ID: 9458437
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives].
    Saji T; Nakayama T; Ishikita T; Matsuura H
    Nihon Rinsho; 2001 Jun; 59(6):1132-8. PubMed ID: 11411125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma.
    St-Pierre P; Deschamps A; Cartier R; Basmadjian AJ; Denault AY
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):723-9. PubMed ID: 23623891
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
    Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
    Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
    Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
    Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure.
    Schroeder RA; Wood GL; Plotkin JS; Kuo PC
    Anesth Analg; 2000 Aug; 91(2):291-5. PubMed ID: 10910834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventilation/perfusion ratios in pulmonary arterial hypertension: effects of IV and inhaled prostacyclin derivatives.
    Bratel T; Lagerstrand L; Brodin LA; Nowak J; Randmaa I
    Chest; 2005 Dec; 128(6 Suppl):615S-616S. PubMed ID: 16373868
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right-heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.
    Muzaffar S; Shukla N; Angelini GD; Jeremy JY
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):949-50. PubMed ID: 15573083
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.
    Haché M; Denault A; Bélisle S; Robitaille D; Couture P; Sheridan P; Pellerin M; Babin D; Noël N; Guertin MC; Martineau R; Dupuis J
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):642-9. PubMed ID: 12658208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pulmonary vasodilatory effect of inhaled prostacyclin and milrinone in heart].
    Ricksten S
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):460-1. PubMed ID: 11792300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
    Gomberg-Maitland M; Preston IR
    Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin.
    Jerath A; Srinivas C; Vegas A; Brister S
    Anesth Analg; 2010 Feb; 110(2):365-9. PubMed ID: 19933533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current approach to the treatment of pulmonary arterial hypertension and our experience in the Cardiology Department of Medicine Faculty of Ege University].
    Kayikçioğlu M; Kültürsay H
    Turk Kardiyol Dern Ars; 2009 Dec; 37(8):580-90. PubMed ID: 20200464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.